CFGS
JAZZ icon

Concourse Financial Group Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Concourse Financial Group Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-372
Closed -$45K – 1107
2024
Q4 		$45K Buy
372
+24
+7% +$2.83K ﹤0.01% 1262
2024
Q3 		$38.8K Buy
348
+332
+2,075% +$36.4K ﹤0.01% 1275
2024
Q2 		$1.71K Buy
16
+1
+7% +$110 ﹤0.01% 2058
2024
Q1 		$1.81K Hold
15
– – ﹤0.01% 2057
2023
Q4 		$1.84K Buy
15
+1
+7% +$125 ﹤0.01% 2030
2023
Q3 		$1.81K Buy
14
+11
+367% +$1.47K ﹤0.01% 2018
2023
Q2 		$371 Hold
3
– – ﹤0.01% 2247
2023
Q1 		$438 Buy
+3
New +$444 ﹤0.01% 2259
2021
Q4 		– Sell
-4
Closed -$526 – 2424
2021
Q3 		$1K Sell
4
-127
-97% -$19.2K ﹤0.01% 2323
2021
Q2 		$23K Sell
131
-29
-18% -$5.02K ﹤0.01% 1604
2021
Q1 		$26K Sell
160
-8
-5% -$1.32K ﹤0.01% 1482
2020
Q4 		$28K Sell
168
-8
-5% -$1.19K ﹤0.01% 1344
2020
Q3 		$25K Buy
176
+28
+19% +$3.47K ﹤0.01% 1293
2020
Q2 		$16K Buy
148
+12
+9% +$1.33K ﹤0.01% 1368
2020
Q1 		$14K Buy
136
+29
+27% +$3.75K ﹤0.01% 1354
2019
Q4 		$16K Buy
107
+58
+118% +$7.89K ﹤0.01% 1317
2019
Q3 		$6K Sell
49
-113
-70% -$15.1K ﹤0.01% 1276
2019
Q2 		$23K Sell
162
-8
-5% -$1.07K ﹤0.01% 1198
2019
Q1 		$24K Sell
170
-35
-17% -$4.57K ﹤0.01% 1192
2018
Q4 		$25K Buy
205
+129
+170% +$19.1K ﹤0.01% 1050
2018
Q3 		$13K Buy
+76
New +$13.1K ﹤0.01% 1009

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Concourse Financial Group Securities's JAZZ Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 372 shares — an estimated $45K sold.

Concourse Financial Group Securities first reported a position in JAZZ in Q3 2018 and held it in 21 quarters. The position peaked at $45K in Q4 2024. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 372 Jazz Pharmaceuticals shares in Q1 2025, an estimated $45K.
  • Concourse Financial Group Securities first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 21 quarters.
  • Concourse Financial Group Securities's Jazz Pharmaceuticals position peaked at $45K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.